“iSoft loses another senior executive from it’s flagship business unit. Just confirmed from internal source that Keith Kirtland, UK&I Commercial and Sales Director resigned earlier this month.”
The website reports that Kirtland is the fourth sales director in as many years and his departure may affect “overall sales in the UK for this troubled NPfIT supplier”.
In response to the report, an iSoft spokesman said this morning:
“Mr Kirtland left for personal reasons. Tony Bowden, formerly of Initiate, has been appointed business development director for the UK and Ireland business.”
In February, iSOFT reported drops in revenue and profit. iSoft’s share price is close to its 52-week low, though it was up 4% yesterday.
iSoft’s Lorenzo is due to be installed by local service provider CSC in three of the five regions into which the NPfIT scheme in England is split. iSoft’s Lorenzo is also to be sold directly to NHS trusts in England. A renegotiation of CSC’s local service provider contract is now underway to reduce the overall cost to the government of the LSP contracts.
iSoft describes itself as the “world’s largest healthcare information technology company in terms of our global footprint”.
Last month iSoft announced that it has appointed a Group Operations Director, Mike Jackman, and a President, North America, Robert Miller.